Can a PET-CT Be Normal — and Cancer Still Be Present?

Yes. A PET-CT and a biopsy answer different questions. The scan looks at metabolic activity across the whole body; a biopsy examines actual cells in a specific area under a microscope. A negative PET does not override clinical suspicion — your oncologist may still recommend a biopsy if a particular area looks suspicious on examination or on another scan. Tissue testing is the definitive answer, and imaging supports that judgement rather than replacing it.

For some cancers and some sites, yes. MRI gives detailed pictures of soft tissue and is the preferred scan for the brain, liver, spine, and locally advanced pelvic tumours. CT provides a full anatomical picture and is often used alongside PET. Which scan is most useful depends on what your oncologist is looking for and where. If your cancer type has known limitations on PET, your team will usually combine scans or use the more appropriate alternative.

PET-CT can only reliably detect deposits above a certain size, and very small collections of cancer cells can fall below what the scan can resolve. The threshold is smaller for FDG-avid tumours than for low-avidity ones. Your oncologist is aware of these limits and factors them into how they read your result. A normal scan is not the same as a clean scan when very small deposits are what is being searched for.

For FDG-avid cancers, a normal or near-normal PET after treatment is one of the ways oncologists assess response, and it can be an encouraging sign. What it means for you specifically depends on what was seen on the previous scan, what cancer type you have, and whether this scan was requested for response assessment or restaging. Ask your oncologist to interpret the result in the context of your care plan rather than reading the report alone.

PET-CT provides information that CT or MRI alone cannot — particularly about whether tissue is metabolically active and whether cancer has spread to distant sites. Even for cancers where PET has limits, it can still detect spread that other scans miss. Your oncologist weighs what the scan is likely to add against its limitations before requesting it. A limitation does not make a scan the wrong choice; it means the result needs to be read with that limitation in mind.

Yes, and it is entirely reasonable. If your symptoms continue, if the result is unexpected given your clinical picture, or if you simply feel uncertain, asking another oncologist or radiologist to review the same images is a sensible step. A second opinion on imaging usually means reviewing the existing images rather than repeating the scan. Your team at CION can advise whether this would add value in your situation and help you arrange it.